GENEREX BIOTECHNOLOGY CORPORATION Annual Base Salaries for Executive Officers Effective January1, 2008
EX-10.33 3 v128470_ex10-33.htm
Exhibit 10.33
GENEREX BIOTECHNOLOGY CORPORATION
Annual Base Salaries for Executive Officers Effective January 1, 2008
On May 6, 2008, the Board of Directors of Generex Biotechnology Corporation implemented changes in annual base salary for its executive officers retroactive to the effective date of January 1, 2008 as follows:
| | Annual Base Salary | |||
| Executive Officer | Increase Effective as of January 1, 2008 | |||
| Anna E. Gluskin Chairman of the Board of Directors, President and Chief Executive Officer | $ | 525,000 | ||
| Rose C. Perri Chief Operating Officer, Chief Financial Officer, Treasurer Secretary and Director | $ | 420,000 | ||
| Mark Fletcher Executive Vice President and General Counsel | $ | 315,000 | ||
